IRIS
MICALE, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.588
AS - Asia 2.328
EU - Europa 2.324
SA - Sud America 446
AF - Africa 221
Continente sconosciuto - Info sul continente non disponibili 203
OC - Oceania 2
Totale 10.112
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.392
SG - Singapore 1.165
RU - Federazione Russa 715
CN - Cina 625
IT - Italia 521
IE - Irlanda 363
BR - Brasile 362
VN - Vietnam 191
UA - Ucraina 161
CA - Canada 150
FR - Francia 120
CI - Costa d'Avorio 107
KR - Corea 85
IN - India 73
GB - Regno Unito 72
DE - Germania 68
ES - Italia 50
SE - Svezia 44
NG - Nigeria 43
PL - Polonia 42
NL - Olanda 41
FI - Finlandia 31
HK - Hong Kong 31
CZ - Repubblica Ceca 30
MX - Messico 28
SN - Senegal 28
AR - Argentina 26
BD - Bangladesh 25
TR - Turchia 22
JP - Giappone 17
IQ - Iraq 16
ZA - Sudafrica 15
EC - Ecuador 14
ID - Indonesia 14
PK - Pakistan 13
VE - Venezuela 12
CH - Svizzera 11
CO - Colombia 11
GR - Grecia 8
KE - Kenya 8
AE - Emirati Arabi Uniti 7
AT - Austria 7
BE - Belgio 7
DK - Danimarca 7
LB - Libano 7
BG - Bulgaria 6
CL - Cile 6
UZ - Uzbekistan 6
BJ - Benin 5
SA - Arabia Saudita 5
EU - Europa 4
IR - Iran 4
LT - Lituania 4
PE - Perù 4
TN - Tunisia 4
UY - Uruguay 4
AZ - Azerbaigian 3
BO - Bolivia 3
DZ - Algeria 3
KZ - Kazakistan 3
MA - Marocco 3
PS - Palestinian Territory 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AU - Australia 2
BB - Barbados 2
CR - Costa Rica 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
OM - Oman 2
PH - Filippine 2
RO - Romania 2
RS - Serbia 2
ZW - Zimbabwe 2
AL - Albania 1
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
JO - Giordania 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SM - San Marino 1
Totale 9.910
Salva come PNG Salva come JPEG
Città #
Santa Clara 775
Singapore 666
Dallas 648
Dublin 345
San Jose 331
Chandler 301
Moscow 253
Jacksonville 237
Chicago 207
Ashburn 182
Boardman 139
Hefei 115
Catania 112
Abidjan 107
Lauterbourg 94
Cambridge 92
Lawrence 92
Andover 90
Toronto 86
Nanjing 85
Seoul 85
Los Angeles 82
Des Moines 66
Beijing 65
Ho Chi Minh City 57
New York 49
Hanoi 48
Houston 45
Council Bluffs 42
Civitanova Marche 35
Nanchang 32
São Paulo 32
Hebei 30
Rome 30
Messina 29
Dakar 28
Hong Kong 28
Ottawa 28
Amsterdam 27
Hyderabad 26
Saint Petersburg 24
Buffalo 23
Prague 23
Tianjin 23
Shenyang 22
Brooklyn 21
Changsha 21
Lagos 21
Abuja 20
Munich 20
Jiaxing 19
Orem 18
San Mateo 18
Wilmington 18
Barcelona 17
Warsaw 17
Montreal 16
Poplar 15
Tokyo 15
Atlanta 14
Denver 14
Florence 13
Haiphong 13
Lappeenranta 13
Phoenix 13
Columbus 12
Krakow 12
Palermo 12
The Dalles 12
Chennai 11
Johannesburg 11
San Francisco 11
Seattle 11
Augusta 10
Belo Horizonte 10
Boston 10
London 10
Madrid 10
Zhengzhou 10
Da Nang 9
Frankfurt am Main 9
Jinan 9
Philadelphia 9
Guangzhou 8
Helsinki 8
Manchester 8
Mexico City 8
Stockholm 8
Ankara 7
Brussels 7
Dong Ket 7
Hangzhou 7
Mumbai 7
Turku 7
Berlin 6
Biên Hòa 6
Istanbul 6
Jakarta 6
Katowice 6
Redwood City 6
Totale 6.578
Salva come PNG Salva come JPEG
Nome #
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 166
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicity 160
Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets 153
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 151
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems 148
Fluoxetine Protects Retinal Ischemic Damage in Mice 143
Behavioral effects of the β3 adrenoceptor agonist SR58611A: Is it the putative prototype of a new class of antidepressant/anxiolytic drugs? 140
Beavioral effects of SR 58611A, a beta-3 agonist, on experimental models of mild stress 139
Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions 136
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 134
Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels 134
Behavioral effects of dietary cholesterol in rats tested in experimental models of mild stress and cognition tasks 131
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia 131
The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes 129
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: analyses in patients and perinatal Δ9-tetrahydrocannabinol-exposed rats 126
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology 125
Altro che Marijuana : i molteplici ruoli delle sostanze cannabinoidi endogene 124
Behavioral modifications induced by dietary cholesterol in rats 124
Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats 124
Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade 123
Amnesia induced by beta-amyloid peptide in dopamine D3 knock-out (KO) mice Is affectedby a cannabinoid CB1 receptor antagonist 123
Systemic depletion of histone macroH2A1.1 boosts hippocampal synaptic plasticity and social behavior in mice 122
Behavioral and molecular effects of repeated treatment with citalopram alone or combined with memantine in rats 117
Early modulation of the endocannabinoid tone prevents molecular and behavioral alterations in MAM model of schizophrenia 116
Attuali orientamenti terapeutici della malattia di Parkinson 115
Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats 115
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis 112
Behavioral effects of ABIO 09/01, a CaMKII inhibitor, on experimental models of depression and anxiety 111
Behavioral and pharmacokinetic profile of indole-derived synthetic cannabinoids JWH-073 and JWH-210 as compared to the phytocannabinoid 19-THC in rats 111
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels 109
The cannabinoid CB1 antagonist TM38837 with limited penetrance to the brain shows reduced fear-promoting effects in mice 108
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons 107
Endocannabinoids and neurodegenerative diseases 106
Red Flags in Primary Mitochondrial Diseases: What Should We Recognize? 103
Cannabidiol and the central nervous system: translating into clinics 102
Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia 100
The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats 97
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia 97
Melatonin affects the immobility time of rats in the forced swim test: The role of serotonin neurotransmission 95
Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia 95
DNA methylation at cannabinoid type 1 and dopamine D2 receptor genes in saliva samples of psychotic subjects: Is there an effect of Cannabis use? 93
Role of the endocannabinoid system and vanilloid TRPV1 channels in the phenotype of dopamine D3 receptor knock-out mice 93
Topically administered NOX4 inhibitor, GLX7013114, is efficacious in treating the early pathological events of diabetic retinopathy 91
Cannabinoid CB1 receptor blockade effects memory capacity of dopamine D3 KO mice pre-treated with β-amyloid peptide 90
Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment 90
“Prescription pattern of antiepileptics in primary care in Italy upon recognition of new indications for reimbursement“. 89
Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats 88
Dopamine D(3) receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepam 86
Sex Differences in the Reinstatement of Methamphetamine Seeking after Forced Abstinence in Sprague-Dawley Rats 86
Effects of citalopram combined with memantine in forced swimming test in rats 86
Long-lasting neurotoxicity of prenatal benzene acute exposure in rats 85
Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: Obligatory role of hippocampal GPR55 receptors 84
Prenatal Exposure to Δ9-Tetrahydrocannabinol Affects Hippocampus-Related Cognitive Functions in the Adolescent Rat Offspring: Focus on Specific Markers of Neuroplasticity 84
Therapeutic potential of cannabinoids in schizophrenia 83
Binge-like alcohol exposure in adolescence: behavioural, neuroendocrine and molecular evidence of abnormal neuroplasticity … and return 83
Placebo affects the performance of rats in models of depression: is it a good control for behavioral experiments? 82
Dual effects of melatonin on barbiturate-induced narcosis in rats 82
Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus 82
Involvement of NK2 receptors in experimental models of anxiety and depression under basal and stress-related conditions 81
Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia 80
Deficiency of histone variant macroH2A1.1 is associated with sexually dimorphic obesity in mice 79
HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animals 79
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms 78
Dynamic DNA methylation programs persistent adverse effects of early-life stress 78
Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test) 78
Increased sensitivity to antidepressants of D(3) dopamine receptor-deficient mice in the forced swim test (FST) 77
Parkin expression profile in dopamine d3 receptor knock-out mice brains 77
Use of phenylethanolaminotetralines for preparing anxiolytic drugs 77
Vitamin D and depression in women: a mini-review 77
Biocompatibility of a genetically encoded calcium indicator in a transgenic mouse model 76
Dopaminergic drugs may counteract behavioral and biochemical changes induced by models of brain injury 76
The amnesic effects induced by β-amyloidfragment 1–42 involve cannabinoid neurotransmission in the brain 76
Endocannabinoid system and mood disorders: Priming a target for new therapies 76
Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon? 75
Enhanced cognitive performance of dopamine D3 receptor "knock-out" mice in the step-through passive-avoidance test: assessing the role of the endocannabinoid/endovanilloid systems 75
Lack of interaction of endocannabinoids and 5-HT(3) neurotransmission in associative fear circuits of the amygdala: evidence from electrophysiological and behavioural experiments 75
D3 dopamine receptor knockout mice: behavioral alteration in experimental models of anxiety 74
The beta3 adrenoceptor agonist amibegron counteracts stress-induced behavioural and neurobiological changes 74
Hippocampal neuroplasticity is involved in the antidepressant-like effects of 5HT4 receptor partial agonist SL 65.0155 73
Endocannabinoid system genes regulation in schizophrenia 73
Interacting effects of the MAM model of schizophrenia and antipsychotic treatment: Untargeted proteomics approach in adipose tissue 73
Nociceptin/orphanin FQ opioid receptor (NOP) selective ligand MCOPPB links anxiolytic and senolytic effects 73
Olanzapine, but not haloperidol, exerts pronounced acute metabolic effects in the methylazoxymethanol rat model 72
Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia 72
Dysregulation of endocannabinoid system in schizophrenia: the potential role of cannabinoid 1 receptor altered gene expression 72
Signaling through cGMP-dependent protein kinase I in the amygdala is critical for auditory-cued fear memory and long-term potentiation 71
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors. 71
Prenatal influences facilitate the precipitation of a schizophrenia-like phenotype: assessing the role of the endocannabinoid system 70
Increased levels of conditioned fear and avoidance behavior coincide with changes in phosphorylation of the protein kinase B (AKT) within the amygdala in a mouse model of extremes in trait anxiety 70
Endocannabinoid system, stress and HPA axis 70
Structural and behavioural changes in a rodent developmental disruption model of schizophrenia 69
Prolonged fear incubation leads to generalized avoidance behavior in mice 68
Use of phenylethanolaminotetralines for preparing anxiolytic drugs 68
Cognitive effects of SL650155, a 5HT4 receptor partial agonist, in animal models of amnesia 68
Memory performance of dopamine D3 knock-out mice (KO) mice pre-treated with beta-amyloid peptide is affected by cannabinoid CB1 receptor antagonist 67
Metabolic profile of methylazoxymethanol model of schizophrenia in rats and effects of three antipsychotics in long-acting formulation 67
Olanzapine, but not haloperiool, improves cognitive performance in an animal model of amnesia induced by β-amyloid peptides 65
Early pharmacological modulation of the endogenous cannabinoid signaling counteracts the phenotype in a rodent developmental disruption model of schizophrenia at adulthood 65
Prenatal MAM exposure raises kynurenic acid levels in the prefrontal cortex of adult rats 65
Parkin expression in dopamine D3 receptor Knock out mice 63
Totale 9.522
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.654
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.654
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022570 0 89 7 23 99 11 95 35 32 2 12 165
2022/20231.050 97 49 12 84 87 186 10 184 262 3 42 34
2023/2024444 31 67 26 32 18 53 4 14 34 17 92 56
2024/20252.327 30 334 127 119 575 352 41 82 162 178 145 182
2025/20264.355 285 192 774 311 611 801 534 109 234 180 244 80
2026/2027115 100 15 0 0 0 0 0 0 0 0 0 0
Totale 10.112